Literature DB >> 9422423

Ten years of liver transplantation: an evolving understanding of late graft loss.

O Abbasoglu1, M F Levy, B B Brkic, G Testa, D R Jeyarajah, R M Goldstein, B S Husberg, T A Gonwa, G B Klintmalm.   

Abstract

BACKGROUND: We undertook this study to understand the causes of late graft loss and long-term outcome in orthotopic liver transplantation (OLT) recipients.
METHODS: Prospectively collected data of 1174 consecutive OLT in 1045 adult patients who received liver grafts between April 1985 and August 1995 were reviewed. The causes of graft loss, pretransplant patient characteristics, and posttransplant events were analyzed in patients who survived at least 1 year after OLT, in an attempt to establish a link between these factors and graft loss.
RESULTS: One hundred fifty-nine (17.9%) grafts were lost after the first year. Of these, 132 grafts were lost by death and 27 by retransplantation. Recipients who survived the first year (n=884) had 5- and 10-year survivals of 81.4% and 67.2%, respectively. Death with a functioning graft occurred in 97 (61%) patients. The main causes of late graft loss were recurrent disease (n=48), cardiovascular and cerebral vascular accidents (n=28), infections (n=24), and chronic rejection (n = 15). Pretransplant heart disease and diabetes were found to be significant risk factors for late graft loss due to cardiovascular diseases and cerebral vascular accidents.
CONCLUSIONS: Survival of OLT patients who live beyond the first posttransplant year is excellent. Some patient characteristics may be associated with late graft loss. Compared with previous reports, this study shows an increased incidence of late graft loss secondary to recurrent diseases, de novo malignancies, cardiovascular diseases, and cerebral vascular accidents. Chronic rejection seems to be a less frequent cause of late graft loss. The prevention of recurrent disease and better immunosuppression may further improve these results.

Entities:  

Mesh:

Year:  1997        PMID: 9422423     DOI: 10.1097/00007890-199712270-00030

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  19 in total

1.  Tacrolimus/cerivastatin interaction study in liver transplant recipients.

Authors:  W Mück; D A Neal; O Boix; B Voith; R Hasan; G J Alexander
Journal:  Br J Clin Pharmacol       Date:  2001-08       Impact factor: 4.335

2.  Liver transplantation for hepatocellular carcinoma.

Authors:  A W Hemming; M S Cattral; A I Reed; W J Van Der Werf; P D Greig; R J Howard
Journal:  Ann Surg       Date:  2001-05       Impact factor: 12.969

3.  Biliary strictures after liver transplantation.

Authors:  Choong Heon Ryu; Sung Koo Lee
Journal:  Gut Liver       Date:  2011-06-23       Impact factor: 4.519

4.  Long-term survival after liver transplantation in 4,000 consecutive patients at a single center.

Authors:  A Jain; J Reyes; R Kashyap; S F Dodson; A J Demetris; K Ruppert; K Abu-Elmagd; W Marsh; J Madariaga; G Mazariegos; D Geller; C A Bonham; T Gayowski; T Cacciarelli; P Fontes; T E Starzl; J J Fung
Journal:  Ann Surg       Date:  2000-10       Impact factor: 12.969

5.  Outcome of Liver Transplant Recipients With Revascularized Coronary Artery Disease: A Comparative Analysis With and Without Cardiovascular Risk Factors.

Authors:  Sanjaya K Satapathy; Jason M Vanatta; Ryan A Helmick; Albert Flowers; Satish K Kedia; Yu Jiang; Bilal Ali; James Eason; Satheesh P Nair; Uzoma N Ibebuogu
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

Review 6.  Immune monitoring post liver transplant.

Authors:  Siddharth Sood; Adam G Testro
Journal:  World J Transplant       Date:  2014-03-24

7.  Evaluation of liver transplant recipients.

Authors:  Paul J Thuluvath
Journal:  J Clin Exp Hepatol       Date:  2012-01-02

8.  The effect of kidney diseases on survival in liver transplant patients.

Authors:  Inci Süleymanlar; Vural Taner Yılmaz; Hüseyin Koçak; Ayhan Dinçkan; Alihan Gürkan; Fevzi Ersoy; Gültekin Süleymanlar
Journal:  Int Urol Nephrol       Date:  2010-08-05       Impact factor: 2.370

9.  Liver transplantation.

Authors:  Deok-Bog Moon; Sung-Gyu Lee
Journal:  Gut Liver       Date:  2009-09-30       Impact factor: 4.519

Review 10.  Single-agent immunosuppression after liver transplantation: what is possible?

Authors:  Maria L Raimondo; Andrew K Burroughs
Journal:  Drugs       Date:  2002       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.